Jasper Therapeutics, Inc.

NASDAQ:JSPR

5.39 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -71.269-64.465-37.685-30.637-31.669-4.987
Depreciation & Amortization 1.3731.1080.9750.3770.0210
Deferred Income Tax 0003.001-0.0210
Stock Based Compensation 6.6195.2114.0911.0481.210.006
Change In Working Capital 0.1735.103-0.6491.6211.2961.392
Accounts Receivables 00.663-0.6630.600
Inventory 000.663-0.600
Accounts Payables -0.1222.381-2.1512.9380.3580
Other Working Capital 0.2952.0591.502-1.3170.9381.392
Other Non Cash Items 0.5020.976-12.59-9.08810.8961.62
Operating Cash Flow -62.602-52.067-45.858-33.678-18.267-1.969
Investing Activities:
Investments In Property Plant And Equipment -0.552-0.267-0.576-2.42800
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 0.020000.1980
Investing Cash Flow -0.532-0.267-0.576-2.4280.1980
Financing Activities:
Debt Repayment 000001.5
Common Stock Issued 47.195101.9310.05510.7511.2870
Common Stock Repurchased 000.028000
Dividends Paid 000000
Other Financing Activities 0.689-0.0560.055100.96911.28727.628
Financing Cash Flow 47.884100.9710.055100.96911.28729.128
Other Information:
Effect Of Forex Changes On Cash 0000-0.1980
Net Change In Cash -15.2548.637-46.37964.863-6.9827.163
Cash At End Of Period 72.05487.30438.66785.04620.18327.163